Keyphrases
Ad26
75%
Anticoagulation Clinic
53%
AS03
45%
Central Laboratory
56%
Chorea
34%
CoaguChek XS
68%
Coagulation Analyzer
45%
Correction Method
45%
COVID-19
61%
COVID-19 Booster Vaccine
30%
COVID-19 Risk
45%
Diabetic Ketoacidosis
45%
Febrile Illness
45%
Focal Segmental Glomerulosclerosis
45%
Fungemia
45%
H7N9 Influenza Virus
45%
H7N9 Vaccine
45%
Hemichorea
45%
Heterologous Boost
45%
Immunogenicity
90%
Kidney Transplant Recipients
45%
Malassezia Pachydermatis
45%
MF59
36%
MRNA Vaccine
45%
Multibacillary Leprosy
45%
Murine Typhus
90%
Natural Infection
45%
Neutralizing Antibodies
90%
NVX-CoV2373
45%
Omicron Variant
45%
Patient Care
53%
Portable Coagulometer
45%
Previous Infection
45%
Priming Regimens
45%
Pseudovirus
45%
PT-INR
90%
Randomized Clinical Trial
45%
Rapid Decline
45%
Renal Failure
45%
Rickettsia Typhi
30%
SARS-CoV-2 Variants
45%
Siemens
68%
Stago
60%
Thromboplastin
56%
Titer
30%
Vaccination
45%
Vaccine Response
60%
Varicella Vaccine
45%
Varicella Zoster Virus
36%
Varicella-zoster Virus Infection
45%
Medicine and Dentistry
Acute Kidney Injury
22%
Acute Tubular Necrosis
22%
Antibody Response
11%
Arm
11%
Avian Influenza
45%
Bloodstream Infection
15%
Booster Dose
45%
Chickenpox
45%
Chickenpox Vaccine
34%
Chorea
34%
Chorea Minor
11%
COVID-19
22%
Diabetic Ketoacidosis
45%
Disease
79%
Endothelial Dysfunction
22%
Focal Segmental Glomerulosclerosis
45%
Fungemia
45%
Hemagglutination Inhibiting Antibody
22%
Humoral Immunity
11%
Hyperglycemia
22%
Immunoassay
11%
Immunogenicity
90%
Infection
26%
Influenza A (H7N9)
45%
Influenza A Virus (H7N9)
34%
Ketoacidosis
11%
Kidney Graft
45%
Kidney Injury
22%
Malassezia
45%
Maturity Onset Diabetes of the Young
22%
Messenger RNA
22%
Mifamurtide
45%
mRNA Vaccine
11%
Multibacillary Leprosy
45%
Murine Typhus
90%
Neutralizing Antibody
45%
Patient with Type 2 Diabetes
22%
Randomized Clinical Trial
45%
Renal Failure
45%
Rickettsia typhi
30%
Rickettsiosis
22%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
Staphylococcal Bacteremia
15%
Typhus
15%
Uremia
22%
Vaccine Strain
22%
Varicella Zoster Vaccine
22%
Varicella Zoster Virus
45%
Vitamin B12 Deficiency
11%
Water-Electrolyte Imbalance
22%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
11%
AS03
45%
Avian Influenza
45%
Chickenpox
45%
Chickenpox Vaccine
34%
Chorea
34%
Chorea Minor
11%
Comorbidity
9%
Cyanocobalamin Deficiency
11%
Diabetic Ketoacidosis
45%
Disease
37%
Hemagglutination Inhibiting Antibody
18%
Herpes Zoster
11%
Hyperglycemia
22%
Hypothyroidism
11%
Immunoassay
9%
Immunogenicity
90%
Immunosuppressive Agent
11%
Infection
60%
Influenza A (H7N9)
45%
Influenza A Virus (H7N9)
27%
Ketoacidosis
11%
Leporidae
22%
Messenger RNA
60%
Metabolic Acidosis
11%
Metabolic Disorder
22%
MF59
36%
mRNA Vaccine
45%
Neutralizing Antibody
100%
Non Insulin Dependent Diabetes Mellitus
22%
Normal Human
22%
Placebo
12%
Randomized Clinical Trial
45%
Recombinant
22%
SARS Coronavirus
93%
Skin Defect
11%
Thromboplastin
45%
Vaccine Strain
20%
Varicella Zoster Vaccine
22%
Varicella Zoster Virus
45%
Vesicular Rash
11%
Warfarin
45%